First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials

• Wei Ding ,

  Contributed equally to this work with: Wei Ding, Yulin Tan

  Roles Data curation, Investigation, Validation, Writing – original draft

  Affiliations Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China, The Wujin Clinical College of Xuzhou Medical University, Changzhou, China

  ⨯
• Yulin Tan ,

  Contributed equally to this work with: Wei Ding, Yulin Tan

  Roles Data curation, Methodology

  Affiliations Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China, The Wujin Clinical College of Xuzhou Medical University, Changzhou, China

  ⨯
• Yan Qian,

  Roles Methodology, Software

  Affiliation Department of Respiration, Changzhou Second People’s Hospital Affiliated to Nanjing Medical University, Changzhou, China

  ⨯
• Wenbo Xue,

  Roles Formal analysis, Methodology

  Affiliations Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China, The Wujin Clinical College of Xuzhou Medical University, Changzhou, China

  ⨯
• Yibo Wang,

  Roles Methodology

  Affiliations Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China, The Wujin Clinical College of Xuzhou Medical University, Changzhou, China

  ⨯
• Peng Jiang,

  Roles Methodology, Software

  Affiliations Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China, The Wujin Clinical College of Xuzhou Medical University, Changzhou, China

  ⨯
• Xuezhong Xu

  Roles Conceptualization, Validation, Writing – review & editing

  * E-mail: xxzdoctor@163.com

  Affiliations Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China, The Wujin Clinical College of Xuzhou Medical University, Changzhou, China

  http://orcid.org/0000-0001-9232-3381

  ⨯